How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

110 results for

Nikolskys Sign

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

41. ACCF/AHA/SCAI 2013 Update of the Clinical Competence Statement on Coronary Artery Interventional Procedures

convened by conference call and email to finalize the document outline, develop the initial draft, revise the draft per committee feedback, and, ultimately, sign off on the document for external peer review. The ACCF, AHA, and SCAI participated in peer review, resulting in 36 reviewers representing 316 comments. Comments were reviewed and addressed by the writing committee. A member of the ACCF/AHA/ACP Task Force on Clinical Competence and Training served as lead reviewer to ensure that all comments (...) for patients with coronary artery disease. 8. Know the methods to assess functional significance of coronary lesions in the catheterization laboratory. 9. STEMI: know the roles of time of presentation, facility capability, anticipated door-to-device time, presence or absence of ongoing symptoms, and ECG abnormalities on the selection of reperfusion strategy. 10. Know the signs and hemodynamics of cardiac dysfunction, and their impact on reperfusion strategy and PCI decisions. 11. Know the limitations

2013 Society for Cardiovascular Angiography and Interventions

42. ACCF/AHA/SCAI 2013 Update of the Clinical Competence Statement on Coronary Artery Interventional Procedures

; and clinical researchers who have studied PCI outcomes. This writing committee met the College's disclosure requirements for relationships with industry as described in the Preamble. 1.1.2. Document Development and Approval The writing committee convened by conference call and email to finalize the document outline, develop the initial draft, revise the draft per committee feedback, and ultimately, sign off on the document for external peer review. The ACCF, AHA, and SCAI participated in peer review (...) complications such as death, myocardial infarction (MI), stroke, and emergency coronary artery bypass graft (CABG) surgery. The definitionofPCI-related MI has evolved over time, and the currentdefinition is provided below in Section 2.3.2. , Short-term clinical success includes angiographic and procedural success with the subsequent relief of signs and/or symptoms of myocardial ischemia. Long-term clinical success requires that the relief of myocardial ischemia remain durable, persisting for more than 1

2013 American Heart Association

43. Treatment of Anemia in Patients With Heart Disease: A Clinical Practice Guideline From the American College of Physicians (Full text)

Treatment of Anemia in Patients With Heart Disease: A Clinical Practice Guideline From the American College of Physicians Treating Anemia in Patients With Heart Disease | Annals of Internal Medicine | American College of Physicians '); } Sign in below to access your subscription for full content INDIVIDUAL SIGN IN | You will be directed to acponline.org to register and create your Annals account INSTITUTIONAL SIGN IN | | Subscribe to Annals of Internal Medicine . You will be directed (...) -than or equal to) 27%) after percutaneous coronary intervention be transfused? JACC 2009 53 A84 Maluenda G , Lemesle G , Syed A , Collins SD , Ben-Dor I , Li Y . et al Does transfusion for major bleeding after percutaneous coronary intervention impact clinical outcome in patients admitted with normal Hematocrit? JACC 2009 53 A72 Nikolsky E , Mehran R , Sadeghi HM , Grines CL , Cox DA , Garcia E . et al Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction

2013 American College of Physicians PubMed

44. Third Universal Definition of Myocardial Infarction

the infarct-related artery, to estimate the amount of myocardium at risk as well as prognosis, and to determine therapeutic strategy. More profound ST-segment shift or T wave inversion involving multiple leads/territories is associated with a greater degree of myocardial ischaemia and a worse prognosis. Other ECG signs associated with acute myocardial ischaemia include cardiac arrhythmias, intraventricular and atrioventricular conduction delays, and loss of pre-cordial R wave amplitude. Coronary artery (...) in the PR segment, the QRS complex, the ST-segment or the T wave. The earliest manifestations of myocardial ischaemia are typically T wave and ST-segment changes. Increased hyperacute T wave amplitude, with prominent symmetrical T waves in at least two contiguous leads, is an early sign that may precede the elevation of the ST-segment. Transient Q waves may be observed during an episode of acute ischaemia or (rarely) during acute MI with successful reperfusion. lists ST-T wave criteria for the diagnosis

2012 American Heart Association

46. ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 Appropriate Use Criteria for Coronary Revascularization Focused Update

draft, revise the draft per committee feedback, and ultimately sign off on the document for external peer review. All participating organizations participated in peer review, resulting in 48 reviewers representing 1,087 comments. Comments were reviewed and addressed by the writing committee. A member of the ACCF TF CECD served as lead reviewer to ensure that all comments were addressed adequately. Both the Writing Committee and TF CECD approved the final document to be sent for board review

2012 Society for Cardiovascular Angiography and Interventions

47. 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD

achieving these targets is limited by signs or symptoms of hypotension. (2D) 3.1.11:We suggest that an ARB or ACE-I be used in children with CKD in whom treatment with BP-lowering drugs is indicated, irrespective of the level of proteinuria. (2D) *Approximate equivalents for albumin excretion rate per 24 hours—expressed as protein excretion rate per 24 hours, albumin-to-creatinine ratio, protein-to- creatinine ratio, and protein reagent strip results— are given in Table 7, Chapter 1. CKD and risk of AKI (...) local practice for people without CKD (and subsequent treatment should be initiated similarly). (1B) 4.2.4: We suggest that clinicians are familiar with the limitations of non-invasive cardiac tests (e.g., exercise electrocardiography [ECG], nuclear imaging, echocardiography, etc.) in adults with CKD and interpret the results accordingly. (2B) 4.3: CKD AND PERIPHERAL ARTERIAL DISEASE 4.3.1: We recommend that adults with CKD be regularly examined for signs of peripheral arterial disease

2012 National Kidney Foundation

48. KDIGO Clinical Practice Guideline for Acute Kidney Injury

KidneyDisease:Improving GlobalOutcomes (KDIGO) makes everyeffort to avoid any actual or reasonably perceived con?icts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the Work Group. All members of the Work Group are required to complete, sign, and submit a disclosure and attestation form showing all such relationships that might be perceived or actual con?icts of interest. This documentisupdatedannually andinformation

2012 National Kidney Foundation

53. Extracranial Carotid and Vertebral Artery Disease: Guideline on the Management of Patients With

Lesions in the Extracranial Carotid Arteries e27 3.3. Symptoms and Signs of Transient Ischemic Attack and Ischemic Stroke e29 3.3.1. Public Awareness of Stroke Risk Factors and Warning Indicators e29 4. Clinical Assessment of Patients With Focal Cerebral Ischemic Symptoms e29 4.1. Acute Ischemic Stroke e29 4.2. Transient Ischemic Attack e29 4.3. Amaurosis Fugax e29 4.4. Cerebral Ischemia Due to Intracranial Arterial Stenosis and Occlusion e30 4.5. Atherosclerotic Disease of the Aortic Arch as a Cause (...) of Cerebral Ischemia e30 4.6. Atypical Clinical Presentations and Neurological Symptoms Bearing an Uncertain Relationship to Extracranial Carotid and Vertebral Artery Disease e30 5. Diagnosis and Testing e30 5.1. Recommendations for Diagnostic Testing in Patients With Symptoms or Signs of Extracranial Carotid Artery Disease e30 5.2. Carotid Duplex Ultrasonography e32 5.3. Magnetic Resonance Angiography e33 5.4. Computed Tomographic Angiography e34 5.5. Catheter-Based Contrast Angiography e35 5.6

2011 American College of Cardiology

54. Guideline on the management of patients with extracranial carotid and vertebral artery disease

. Clinical Presentation .e64 3.1. Natural History of Atherosclerotic Carotid Artery Disease .e64 3.2. Characterization of Atherosclerotic Lesions in the Extracranial Carotid Arteries .e66 3.3. Symptoms and Signs of Transient Ischemic Attack and Ischemic Stroke .e66 3.3.1. Public Awareness of Stroke Risk Factors and Warning Indicators .e66 4. Clinical Assessment of Patients With Focal Cerebral Ischemic Symptoms .e67 4.1. Acute Ischemic Stroke .e67 4.2. Transient Ischemic Attack .e67 4.3. Amaurosis Fugax (...) .e67 4.4. Cerebral Ischemia Due to Intracranial Arterial Stenosis and Occlusion .e67 4.5. Atherosclerotic Disease of the Aortic Arch as a Cause of Cerebral Ischemia .e68 4.6. Atypical Clinical Presentations and Neurological Symptoms Bearing an Uncertain Relationship to Extracranial Carotid and Vertebral Artery Disease .e68 5. Diagnosis and Testing .e68 5.1. Recommendations for Diagnostic Testing in Patients With Symptoms or Signs of Extracranial Carotid Artery Disease .e68 5.2. Carotid Duplex

2011 American Academy of Neurology

55. Guideline on the Management of Patients with Extracranial Carotid and Vertebral Artery Disease

. Clinical Presentation .e64 3.1. Natural History of Atherosclerotic Carotid Artery Disease .e64 3.2. Characterization of Atherosclerotic Lesions in the Extracranial Carotid Arteries .e66 3.3. Symptoms and Signs of Transient Ischemic Attack and Ischemic Stroke .e66 3.3.1. Public Awareness of Stroke Risk Factors and Warning Indicators .e66 4. Clinical Assessment of Patients With Focal Cerebral Ischemic Symptoms .e67 4.1. Acute Ischemic Stroke .e67 4.2. Transient Ischemic Attack .e67 4.3. Amaurosis Fugax (...) .e67 4.4. Cerebral Ischemia Due to Intracranial Arterial Stenosis and Occlusion .e67 4.5. Atherosclerotic Disease of the Aortic Arch as a Cause of Cerebral Ischemia .e68 4.6. Atypical Clinical Presentations and Neurological Symptoms Bearing an Uncertain Relationship to Extracranial Carotid and Vertebral Artery Disease .e68 5. Diagnosis and Testing .e68 5.1. Recommendations for Diagnostic Testing in Patients With Symptoms or Signs of Extracranial Carotid Artery Disease .e68 5.2. Carotid Duplex

2011 Congress of Neurological Surgeons

56. Cyclosporine and Etanercept in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

) Sexes Eligible for Study: All Accepts Healthy Volunteers: No Criteria Inclusion Criteria: Inclusion will be considered if there are 3 or more of: Clinical Criteria Erythematous to dusky macules that show evidence of coalescing AND/OR denuding skin or blistering in a predominantly truncal distribution. Nikolsky sign (sloughing with direct lateral pressure on non-blistered, but involved, skin) is considered to be a supportive feature. Mucous membrane involvement Prodromal symptoms including fever (...) : Placebos Intravenous and subcutaneous saline to match cyclosporine and etanercept in an identical delivery container/syringe Outcome Measures Go to Primary Outcome Measures : Time to complete re-epithelialization [ Time Frame: 3 weeks ] Absence of erosion and compromised skin Secondary Outcome Measures : Time to first sign of healing or halting of disease progression [ Time Frame: 2 weeks ] No new lesions, cessation of denudation of skin, or any sign of reversal of sloughing All-cause mortality [ Time

2016 Clinical Trials

57. Determining the Optimal Cut-off Point of PEA by Corsens Device for Discriminating Between MI and Non-MI Subjects

Medical LTD. Recruitment status was: Not yet recruiting First Posted : March 31, 2016 Last Update Posted : March 31, 2016 Sponsor: Corsens Medical LTD Information provided by (Responsible Party): Corsens Medical LTD Study Details Study Description Go to Brief Summary: Acute Myocardial Infarction (MI) is still the leading cause of death in the western world. Early warning (chest pain) signs of an acute MI are often misinterpreted and disregarded. In average it takes between 2-3 hours from the beginning (...) as evidenced by signing the written informed consent. Exclusion Criteria: Obese patients with BMI>35. Subjects with cardiac arrhythmias including atrial fibrillation. Previous MI. Patients after coronary artery bypass grafting Unstable hemodynamic condition. Patient that can't or do not wish to sign the Inform Consent Form Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact

2016 Clinical Trials

58. Phenytoin induced Steven–Johnson syndrome and bronchiolitis obliterans – case report and review of literature (Full text)

with minimal force (Nikolsky's sign). SJS is typically diagnosed when less than 10% of the skin surface is involved and the term TEN is used in cases with more than 30% involvement. Respiratory involvement in SJS-TEN is common with 30-50% of cases demonstrating respiratory epithelial sloughing with severe short and long term complications. Patients who survive SJS-TEN are often left with impaired respiratory function and bronchiolitis obliterans. Cases of bronchiolitis obliterans with SJS/TEN have been

2016 Respiratory Medicine Case Reports PubMed

59. Regular exploratory examination of the need for DMP revision - a feasibility study using the example of the DMP "CHD"

-ÄndV Risikostrukturausgleichsänderungsverordnung SIGN Scottish Intercollegiate Guideline Network SR systematic review (systematische Übersicht) SGB Sozialgesetzbuch STEMI ST-elevation myocardial infarction (Myokardinfarkt mit ST- Streckenhebung) VStG Versorgungsstrukturgesetz WHO World Health Organization Arbeitspapier GA14-06 Version 1.0 DMP Überprüfung 07.10.2014 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) - xiv - Kurzfassung Das Institut für Qualität und

2015 Institute for Quality and Efficiency in Healthcare (IQWiG)

60. Pemphigus Foliaceus (Overview)

skin that blisters when rubbed (the Nikolsky sign; commonly but incorrectly spelled Nicholsky), a finding named after Dr Piotr Nikolsky, who first described this sign in 1896. [ ] Pemphigus foliaceus is characterized by a chronic course, with little or no involvement of the mucous membranes. Pierre Louis Alphee Cazenave, founder of the first journal dedicated entirely to dermatology, documented the first description of pemphigus foliaceus in 1844 in this journal. The description was of a 47-year (...) -old woman who consulted him at l'Hopital Saint Louis in Paris for a generalized eruption of several years' duration. Nikolsky described lateral extension of the preexisting erosion due to lifting up the collarette (and when applying a lateral pressure to the clinically intact skin), whereas Asboe-Hansen described extension of the intact blister due to pressure that is applied to its roof. Pemphigus foliaceus has the following six subtypes: pemphigus erythematosus (PE), pemphigus herpetiformis (PH

2014 eMedicine.com

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>